Mallinckrodt Pharmaceuticals
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- -
- Established
- 2013-01-01
- Employees
- -
- Market Cap
- $4.5M
- Website
- http://www.mallinckrodt.com/
Yaqrit Advances L-ornithine Phenylacetate to Phase 3 for Acute Hepatic Encephalopathy Treatment
Yaqrit's subsidiary Amalive is preparing to launch Phase 3 trials in 2025 for L-ornithine phenylacetate (OPA), an ammonia scavenger acquired from Mallinckrodt Pharmaceuticals, targeting acute hepatic encephalopathy.